Loading…
5 companies · GEL, thousands · columns ordered by revenue
| Line item | Endokrinologiis Erovnul… | Curatio | Med Investment | Adiktologiis Regionalur… | Reimani |
|---|---|---|---|---|---|
| Total Revenue | 14,193 | 13,274 | 11,967 | 11,629 | 7,773 |
| Total COGS | -1,530 | -418 | 0 | 0 | -5,535 |
| Gross Profit | 12,663 | 12,856 | 11,967 | 11,629 | 2,238 |
| Gross Margin | 89.2% | 96.9% | 100.0% | 100.0% | 28.8% |
| Total Operating Expenses | -9,180 | -10,737 | -13,616 | -8,696 | -3,618 |
| EBITDA | 3,484 | 2,119 | -1,649 | 2,933 | -1,380 |
| EBITDA Margin | 24.5% | 16.0% | -13.8% | 25.2% | -17.8% |
| Total D&A | -536 | -454 | -480 | -87 | -178 |
| EBIT / Operating Income | 2,948 | 1,665 | -2,129 | 2,846 | -1,559 |
| Total Interest Expense | -102 | -1,110 | -502 | -124 | -974 |
| Total Other Income | 3 | 90 | -97 | 333 | -148 |
| Profit Before Tax | 2,848 | 645 | -2,539 | 3,055 | -2,681 |
| Total Income Tax | -257 | 0 | 0 | -6 | 0 |
| Net Profit / (Loss) | 2,591 | 645 | -1,822 | 3,049 | -1,620 |
| Net Margin | 18.3% | 4.9% | -15.2% | 26.2% | -20.8% |
| Total Interest Income | — | — | 188 | — | — |
| Company | Sector | EBITDA margin · FY 2023 | Percentile | Sector n |
|---|---|---|---|---|
| Adiktologiis Regionalur… | Healthcare Services | 25.2% | 86th pct | 312 |
| Endokrinologiis Erovnul… | Healthcare Services | 24.5% | 85th pct | 312 |
| Curatio | Healthcare Services | 16.0% | 66th pct | 312 |
| Med Investment | Healthcare Services | -13.8% | 11th pct | 312 |
| Reimani | Healthcare Services | -17.8% | 9th pct | 312 |
Percentile is within each company's own sector across the whole FY2023 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.